Moderate intensity exercise performance | ||||||||
---|---|---|---|---|---|---|---|---|
Women with FM, n = 22 | Healthy reference group, n = 27 | Between-group differences | ||||||
0 min | 15 min–0 min | 0 min | 15 min–0 min | 0 min | Change 0–15 min | |||
Mean ± sd | ∆ mean ± sd | p-value | Mean ± sd | ∆ mean ± sd | p-value | p-value | p-value | |
S-IGF-1 (ng/ml) | 178 ± 58 | 11 ± 10 | <0.001 | 179 ± 69 | 13 ± 10 | <0.001 | 0.825 | 0.629 |
free IGF-I (ng/ml) | 3.5 ± 1.6 | −0.15 ± 0.34 | 0.014 | 4.0 ± 2.09 | −0.38 ± 0.47 | <0.001 | 0.457 | 0.119 |
S-IGFBP3 (ng/ml) | 428 ± 44 | 11 ± 16 | 0.007 | 426 ± 37 | 14 ± 19 | 0.001 | 0.880 | 0.662 |
sCRP (μg/ml) | 2.0 ± 2.2 | 0.14 ± 0.18 | 0.001 | 0.56 ± 0.48 | 0.35 ± 0.46 | <0.001 | <0.001 | 0.215 |
IL-8 (pg/ml) | 9.2 ± 4.5 | −5.9 ± 1.6 | 0.105 | 9.6 ± 2.5 | −0.3 ± 1.0 | 0.077 | 0.769 | 0.600 |
Pain (0–100 mm) | 40 ± 19 | 7.6 ± 16 | 0.044 | 0.8 ± 2.1 | 2.0 ± 6.8 | 0.093 | <0.001 | 0.015 |
Fatigue in legs (0–100 mm) | 26 ± 23 | 28 ± 24 | <0.001 | 1 ± 2.4 | 6.0 ± 8.5 | 0.002 | <0.000 | <0.001 |
Fatigue global (0–100 mm) | 51 ± 27 | 9.2 ± 17 | 0.038 | 4 ± 6.4 | 10 ± 12 | 0.002 | <0.001 | 0.672 |